- Home
- A-Z Publications
- Current HIV Research
- Previous Issues
- Volume 2, Issue 1, 2004
Current HIV Research - Volume 2, Issue 1, 2004
Volume 2, Issue 1, 2004
-
-
Mucosal HIV Vaccines: Where are We Now?
Authors: Liljana Stevceva and Warren StroberAround the world, approximately 5 million people became infected with HIV in 2001, an estimated 70% via sexual transmission. Numerous studies have demonstrated that it is difficult to achieve total protection from vaginally or rectally acquired HIV / SIV when using parenteral immunization. Mucosal immunization was seen as the best approach to achieve sustainable immune responses at mucosal sites of viral entry. This was Read More
-
-
-
B Lymphocyte Dysfunctions in HIV Infection
More LessHIV establishes a chronic and latent infection that is not eliminated by the host immune defences. The virus induces extensive damage to the immune system, through virus-related and indirect pathogenic mechanisms. Both the cellular and the humoral arms of the immune system are unable to control the infection, which ultimately results in severe exhaustion of several lymphocyte functions and increased susceptibilit Read More
-
-
-
CD8+ T-Cells: Function and Response to HIV Infection
Authors: Naveed Gulzar and Karen F.T. CopelandCD8+ T-cells are a critical component of the cellular immune response and they play an important role in the control of viral infection. During HIV infection, CD8+ T-cells are able to recognize infected cells through an MHC-I dependent process and are able to lyse cells harboring viral infection by the secretion of perforin and granzymes. These cytotoxic T-lymphocytes (CTL) can also eliminate virally infected cells through the en Read More
-
-
-
HIV-1 Infection and Chemokine Receptor Modulation
In addition to the CD4 molecule that binds to the human immunodeficiency virus type-1 (HIV-1) envelope glycoprotein gp120, productive HIV-1 infection requires interaction with cellular receptors for α- or β- chemokines (CXCR4 and CCR5 respectively). Isolates of HIV-1 exhibit different tropism depending on the chemokine receptor type that they use to infect their cellular targets. HIV-1 strains that use preferentially CCR Read More
-
-
-
Role of CD4 Receptor Down-regulation During HIV-1 Infection
Authors: Karine Levesque, Andres Finzi, Julie Binette and Eric A. CohenHuman immunodeficiency virus has evolved several redundant mechanisms to remove its receptor, the CD4 molecule, from the cell surface. Indeed, HIV-1 encodes three proteins, Nef, Vpu and Env, that have a profound effect on CD4 trafficking and catabolism. Given this functional convergence, it is believed that cell surface CD4 regulation constitutes an important determinant of viral replication and pathogenesis in Read More
-
-
-
Advances in Neuroimaging for HIV-1 Associated Neurological Dysfunction: Clues to the Diagnosis, Pathogenesis and Therapeutic Monitoring
Persons with advanced human immunodeficiency virus type one (HIV-1) infection seek medical advice for a wide range of neurological disorders including, but not limited to, peripheral neuropathy, toxoplasmosis, cryptococcal meningitis, cytomegalovirus retinitis progressive multifocal leukoencephalopathy, lymphoma and dementia. The diagnosis of HIV-1-associated dementia (HAD) induced as a direct consequence of Read More
-
-
-
The Chaperoning and Assistance Roles of the HIV-1 Nucleocapsid Protein in Proviral DNA Synthesis and Maintenance
Authors: Carole Bampi, Sandrine Jacquenet, Daniela Lener, Didier Decimo and Jean- L. DarlixIn the following three sections we will briefly review the seminal roles of the HIV-1 nucleocapsid protein NCp7 in the fate of the HIV-1 full length RNA from genomic RNA in a dimeric form to the proviral DNA. Emphasis will be given to the mechanisms of NC-directed assistance to the genomic RNA and reverse transcriptase in the course of proviral DNA synthesis and to DNA integrity at the end of the polymerization process, and to t Read More
-
-
-
ERRATUM
Correction to “Regulation of TAK / P-TEFb in CD4+T Lymphocytes and Macrophages” by Andrew P. Rice and Christine H. Herrmann published in Current HIV Research, October 2003, Vol. 1, No. 4, pp. 395-404. The correct figure 4 is given below. Earlier it missed some characters. The publishers regret any inconvenience.
-
Volumes & issues
-
Volume 22 (2024)
-
Volume 21 (2023)
-
Volume 20 (2022)
-
Volume 19 (2021)
-
Volume 18 (2020)
-
Volume 17 (2019)
-
Volume 16 (2018)
-
Volume 15 (2017)
-
Volume 14 (2016)
-
Volume 13 (2015)
-
Volume 12 (2014)
-
Volume 11 (2013)
-
Volume 10 (2012)
-
Volume 9 (2011)
-
Volume 8 (2010)
-
Volume 7 (2009)
-
Volume 6 (2008)
-
Volume 5 (2007)
-
Volume 4 (2006)
-
Volume 3 (2005)
-
Volume 2 (2004)
-
Volume 1 (2003)
Most Read This Month
Article
content/journals/chr
Journal
10
5
false
en
